A new type of bioengineered blood vessel showed strong results in treating severe vascular injuries, potentially offering vascular surgeons a better alternative to synthetic grafts when patients' ...

Are you a houseplant lover? Can’t get enough green, leafy plants? We have some exciting news for you. A French startup called Neoplants recently launched a bioengineered houseplant designed to clean ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Artepillin C is an herbal medicinal product with many beneficial effects on human health. It is commercially available as the active ingredient in Brazilian green propolis but is also produced by a ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...

BALTIMORE--(BUSINESS WIRE)--Pantheon Vision, a preclinical-stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, today announced entering a ...

The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular trauma in the extremities of adults. The one-time, single-use therapy -- the ...